18%, p = 0.04), although NIH-CPSI reductions did not reach statistical significance compared with placebo ( p = 0.068), highlighting the challenges of placebo responsiveness in CP/PPPS studies ( 19 ). 3.2.
← all excerpts
Glycosaminoglycans and hyaluronic acid in chronic prostatitis/primary prostate pain syndrome: an evidence-grounded perspective.
1
0.0680
0.0680